Anti-Influenza Virus Monoclonal Antibody

· Theraclone Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Influenza Virus Monoclonal Antibody, covering 2012-04-02 to 2012-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza [Phase 1]